Cardiovascular Health Markers in Men: Endothelial Function, Inflammation, and ED Connection

This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before beginning any supplement.

By VFM Research Desk | Last verified: July 2026

Male Cardiovascular Health: The Endothelial Foundation and How Supplements Protect It

The Question: Why Is Cardiovascular Disease Still the #1 Killer of Men, and What Can Supplements Actually Do?

Cardiovascular disease (heart attack, stroke, heart failure) kills more men in the United States than all cancers combined. It kills 1 in 4 men — roughly 380,000 men annually. Yet cardiovascular risk is highly modifiable. Most men who develop heart disease could have prevented it through lifestyle changes and evidence-based interventions.

Interestingly, erectile dysfunction (ED) in men under 50 is one of the most specific early warning signs of cardiovascular disease. Why? Because ED and cardiovascular disease share the same fundamental problem: endothelial dysfunction. Understanding this connection — and the multiple biological markers that indicate cardiovascular risk — reveals why supplements targeting single markers often fail, while comprehensive approaches work.

The Mechanism: Endothelial Dysfunction as the Foundation

What the Endothelium Is and Why It Matters

The endothelium is the thin single layer of cells lining all blood vessels in the body — arteries, capillaries, and veins. It’s not passive insulation; it’s an active, dynamic tissue that regulates:

1. **Vascular tone** (blood vessel contraction/relaxation via nitric oxide production)
2. **Vasopermeability** (which molecules can pass through the vessel wall)
3. **Blood coagulation** (preventing clotting; inhibiting platelet aggregation)
4. **Immune responses** (managing inflammatory cell infiltration)
5. **Smooth muscle cell proliferation** (preventing arterial wall thickening)

In healthy young men, the endothelium maintains these functions through production of vasoprotective molecules, primarily nitric oxide (NO). (See the separate research article on the nitric oxide pathway for detailed mechanism.)

The Cascade Into Disease: Endothelial Dysfunction → Atherosclerosis → Heart Disease

Endothelial dysfunction begins when the endothelium’s protective functions deteriorate:

**Stage 1: Endothelial Dysfunction (Silent)**
– Reduced nitric oxide production (from oxidative stress, inflammation, aging)
– Increased endothelial permeability (allows LDL and inflammatory molecules to infiltrate arterial walls)
– Activation of adhesion molecules (ICAM-1, VCAM-1) that recruit inflammatory cells
– Shift from vasodilation toward vasoconstriction
– Loss of anticoagulant function (vessel wall becomes thrombogenic)

This stage produces NO objective symptoms. Blood pressure may still be normal. Cholesterol levels may be normal. Yet damage is occurring at the cellular level.

**Stage 2: Atherosclerotic Plaque Formation (Subclinical)**
– LDL cholesterol infiltrates the arterial wall through damaged endothelium
– LDL is oxidized by free radicals into oxidized LDL (oxLDL), a highly inflammatory form
– Macrophages engulf oxLDL, becoming foam cells
– Foam cells accumulate in the arterial wall, forming the fatty streak — the first visible atherosclerotic lesion
– Smooth muscle cells migrate into the intima (inner arterial wall layer) and proliferate
– Connective tissue and lipids accumulate, forming a growing plaque
– The body attempts to contain the plaque with a fibrous cap, but inflammation prevents cap stabilization

Still no symptoms. Angiograms might not show significant narrowing. Yet 50% of arterial lumen is now occluded.

**Stage 3: Acute Coronary Event (Symptomatic Crisis)**
– Plaque rupture: the weakened fibrous cap tears, exposing thrombogenic material inside the plaque
– Platelet aggregation and coagulation cascade activate (normal hemostatic response to “vessel wall injury”)
– Blood clot (thrombus) forms, occluding the vessel
– Heart muscle supplied by that artery is deprived of oxygen, causing a heart attack
– Alternatively, a stroke occurs if the occlusion is in a cerebral artery

The entire disease progression from endothelial dysfunction to heart attack can take 20-30 years, silently.

The Key Cardiovascular Risk Markers: What They Indicate and How They Interact

Marker #1: Endothelial Function (The Foundation)

**How it’s measured:**
– Flow-mediated dilation (FMD): ultrasound measurement of how much a vessel dilates after a blood pressure cuff is released. Lower dilation = worse endothelial function
– Arterial stiffness: how much an artery stretches under pressure. Stiffer vessels = worse function
– Pulse wave velocity: speed sound travels through arteries. Higher velocity = stiffer, less functional vessels

**What it means:**
– Endothelial dysfunction is the earliest detectable sign of cardiovascular disease, often 10-20 years before heart attack risk becomes high
– Men with poor FMD have 4-6× higher risk of future cardiovascular events compared to men with excellent FMD
– Endothelial dysfunction predicts ED, hypertension, and atherosclerotic disease progression

Marker #2: LDL Cholesterol and LDL Particle Characteristics

Not all LDL is equally atherogenic. The size and oxidation state matter more than the absolute number.

**LDL particle size:**
– Large, buoyant LDL particles: less likely to penetrate damaged endothelium; lower atherogenic risk
– Small, dense LDL particles: easily penetrate endothelium; higher atherogenic risk

**LDL oxidation state:**
– Native LDL (non-oxidized): doesn’t significantly activate macrophages or trigger inflammation
– Oxidized LDL (oxLDL): highly inflammatory; macrophages engulf it, become foam cells, initiates atherosclerosis

**What it means:**
– A man with LDL cholesterol 120 mg/dL composed mostly of large particles has lower risk than a man with LDL 100 mg/dL composed mostly of small particles
– High triglycerides shift LDL toward smaller, denser particles
– High oxidative stress increases oxLDL, accelerating atherosclerosis

**Why this matters for supplements:** Antioxidant supplements (vitamin C, E, lycopene) theoretically reduce oxLDL formation. Supplements that improve triglyceride profile (omega-3, niacin) shift LDL toward larger particles.

Marker #3: HDL Cholesterol (The Protective Factor)

HDL (“good cholesterol”) does the opposite of LDL:
– Reverse cholesterol transport: HDL removes cholesterol from arterial walls and transports it to the liver for excretion
– Anti-inflammatory: HDL suppresses endothelial adhesion molecule expression
– Antithrombotic: HDL inhibits platelet aggregation
– Antioxidant: HDL reduces LDL oxidation

**What it means:**
– Higher HDL is protective, independent of LDL. Men with HDL >50 mg/dL have better prognosis than men with HDL <40 mg/dL - HDL <40 mg/dL in men is a strong independent risk factor for cardiovascular disease **Why this matters for supplements:** Regular aerobic exercise is the most effective HDL raiser (can increase 5-15%). Niacin and certain polyphenols modestly increase HDL.

Marker #4: Triglycerides (The Often-Overlooked Risk Factor)

Elevated triglycerides contribute to atherosclerotic disease through multiple mechanisms:

1. **Shifts LDL toward smaller, denser particles** (more atherogenic)
2. **Increases remnant lipoproteins** (VLDL remnants are atherogenic)
3. **Impairs HDL function** (high triglycerides reduce HDL particle size and number)
4. **Increases inflammation** (high triglycerides are associated with elevated CRP, IL-6)
5. **Impairs endothelial function** (high triglycerides reduce NO production)

**What it means:**
– Triglycerides >150 mg/dL (even with normal LDL and total cholesterol) indicate increased cardiovascular risk
– The ratio of triglycerides to HDL is a particularly strong risk indicator: TG/HDL >2 indicates elevated risk

**Why this matters for supplements:** Omega-3, niacin, and certain polyphenols effectively reduce triglycerides.

Marker #5: Homocysteine (The Controversial But Real Risk Factor)

Homocysteine is an amino acid intermediate in methionine metabolism. Elevated homocysteine:
– Damages endothelial cells directly (oxidative stress, inflammation)
– Oxidizes LDL, promoting atherosclerosis
– Increases thrombotic tendency (increases clotting risk)
– Impairs vasodilation (reduces NO production)

**What it means:**
– Homocysteine >10 μmol/L is elevated; >15 μmol/L is significantly elevated
– Each 5 μmol/L increase in homocysteine increases cardiovascular risk 20-30%
– Homocysteine is modifiable: B vitamins (B6, B12, folate) reduce it

**Why this matters for supplements:** B-complex supplementation (particularly folate, B12, B6) effectively lowers homocysteine, reducing cardiovascular risk.

Marker #6: C-Reactive Protein (CRP) — Systemic Inflammation Marker

CRP is produced by the liver in response to inflammation. Elevated CRP indicates systemic inflammation, which accelerates atherosclerosis through multiple mechanisms:
– Increases endothelial permeability
– Activates adhesion molecules
– Promotes foam cell formation
– Destabilizes atherosclerotic plaques

**What it means:**
– CRP <1.0 mg/L: low risk - CRP 1.0-3.0 mg/L: intermediate risk - CRP >3.0 mg/L: high risk
– CRP is an independent risk factor, predictive even in men with normal LDL

**Why this matters for supplements:** Omega-3, curcumin, resveratrol, and other polyphenols reduce CRP. Weight loss and exercise reduce CRP dramatically.

Marker #7: Blood Pressure (The Mechanical Stressor)

Elevated blood pressure accelerates endothelial dysfunction and atherosclerosis through mechanical stress on vessel walls. Chronic hypertension:
– Damages endothelial cells
– Promotes smooth muscle cell proliferation (arterial wall thickening)
– Increases arterial stiffness
– Impairs autoregulation of blood flow

**What it means:**
– Normal: <120/80 mmHg - Elevated: 120-129/<80 - Stage 1 hypertension: 130-139/80-89 - Stage 2 hypertension: ≥140/≥90 Each 10 mmHg increase in systolic blood pressure increases cardiovascular risk 20-30%. **Why this matters for supplements:** Nitric oxide enhancement (via L-citrulline, beetroot), potassium, magnesium, and other interventions lower blood pressure modestly.

Marker #8: Arterial Calcification (CAC Score)

Coronary artery calcification (CAC) is calcium deposit in atherosclerotic plaques, quantified by CT scan (Agatston score). CAC >0 indicates presence of atherosclerosis.

**What it means:**
– CAC = 0: very low risk
– CAC 1-100: low to intermediate risk
– CAC 101-400: intermediate to high risk
– CAC >400: high risk; significant atherosclerotic burden

CAC score is predictive of future cardiovascular events even in asymptomatic men.

**Why this matters for supplements:** Vitamin K2 and magnesium inhibit arterial calcification (though evidence is emerging; not yet definitive). Calcium supplements may paradoxically increase CAC, so supplement selection matters.

Marker #9: Erectile Function as an Early Warning Sign

This deserves special emphasis because ED is often the first sign of systemic endothelial dysfunction.

**The connection:**
– ED and coronary artery disease share the same pathophysiology: endothelial dysfunction
– The penile arteries are smaller than coronary arteries, so they’re perfusion-limited earlier
– Longitudinal studies show: men with ED have 1.6-2.5× higher risk of heart attack and stroke compared to men with normal ED
– In men under 50 with ED, cardiac disease is present in 30-40% of cases (even if asymptomatic)

**What it means:**
– ED in a young man is not a cosmetic problem; it’s a cardiovascular risk flag
– If a man has ED plus other risk factors (smoking, hypertension, elevated cholesterol, family history), aggressive cardiovascular risk reduction is indicated
– Conversely, ED improvement following cardiovascular interventions signals endothelial healing

**Why this matters for supplements:** Improving endothelial function (via nitric oxide enhancement, inflammation reduction) simultaneously improves both cardiovascular health AND erectile function. This is not coincidence; it’s the same biology.

How Supplements Target These Markers

Omega-3 Fatty Acids: Multi-Target Anti-Inflammatory

**Mechanisms:**
– Reduce triglycerides (by 15-30% at doses 2-4g daily)
– Shift LDL toward larger particle size
– Reduce CRP and other inflammatory markers (20-30% reduction)
– Reduce blood pressure modestly (2-4 mmHg)
– Improve endothelial function (increase NO bioavailability)
– Reduce platelet aggregation (anticoagulant effect)

**Evidence:** Excellent. Multiple large trials (e.g., REDUCE-IT, STRENGTH) show omega-3 supplementation reduces cardiovascular events in patients with elevated triglycerides.

**Clinical relevance:** One of the few supplements with strong evidence of cardiovascular benefit.

Coenzyme Q10 (CoQ10): Mitochondrial Energy and Antioxidant

**Mechanisms:**
– Reduces LDL oxidation (antioxidant effect)
– Improves endothelial function (increases NO production)
– Reduces blood pressure modestly (3-5 mmHg)
– Improves heart function in heart failure patients (may improve cardiac output)
– Reduces statin-induced muscle damage (statins deplete CoQ10)

**Evidence:** Moderate. Consistent evidence for blood pressure reduction and endothelial function improvement. Some evidence for heart failure benefit.

**Clinical relevance:** Particularly useful in men taking statins (which deplete CoQ10). Dose: 100-300mg daily.

Vitamin K2: Arterial Calcification Prevention

**Mechanisms:**
– Activates matrix Gla protein (MGP), which inhibits arterial calcification
– Directs calcium toward bone, away from soft tissues
– May reduce arterial stiffness

**Evidence:** Emerging. Observational studies show men with higher vitamin K2 intake have lower CAC scores. Mechanism is clear from animal studies. Human intervention trials are limited but promising.

**Clinical relevance:** Dietary K2 (from fermented foods, grass-fed dairy, natto) may prevent arterial calcification. Supplemental evidence is less established than dietary sources.

Magnesium: Vascular Relaxation and Inflammation

**Mechanisms:**
– Activates endothelial NO synthase (eNOS), increasing NO production
– Blocks calcium influx into vascular smooth muscle, promoting relaxation
– Reduces inflammation (lowers CRP, IL-6)
– Reduces blood pressure (4-10 mmHg at doses 200-400mg daily)
– Improves endothelial function

**Evidence:** Good. Multiple trials show magnesium supplementation reduces blood pressure and improves arterial function, particularly in men with baseline deficiency.

**Clinical relevance:** Many men are magnesium-deficient (due to poor diet, stress, aging). Supplementation to adequate intake (400-420mg daily for adult men) is indicated.

Lycopene: Antioxidant and Anti-Inflammatory

**Mechanisms:**
– Reduces LDL oxidation (potent antioxidant; more effective than beta-carotene or lutein)
– Reduces CRP and inflammatory markers
– Reduces blood pressure modestly (3-5 mmHg)
– Improves endothelial function

**Evidence:** Moderate. Multiple trials show lycopene (10-30mg daily) reduces oxidative stress markers and improves some cardiovascular parameters. Effects are consistent but modest.

**Clinical relevance:** Easily obtained from diet (tomato products, watermelon, grapefruit). Supplementation provides additional benefit beyond food sources.

Taurine: Antioxidant and Cardiac Function

**Mechanisms:**
– Powerful antioxidant (reduces oxidative stress markers)
– Improves cardiac contractility (heart muscle contraction strength)
– Reduces blood pressure (5-8 mmHg at doses 3-6g daily)
– Improves endothelial function
– Reduces inflammation

**Evidence:** Moderate to good. Multiple trials show taurine improves heart function in heart failure, reduces blood pressure, and improves endothelial function. Mechanisms are clear.

**Clinical relevance:** Taurine 3-6g daily shows consistent cardiovascular benefits. Particularly useful in men with heart failure or reduced ejection fraction.

Polyphenols (Resveratrol, Curcumin, EGCG): Inflammation and Oxidative Stress

**Mechanisms (shared across polyphenols):**
– Reduce CRP and inflammatory cytokines (IL-6, TNF-α)
– Reduce LDL oxidation
– Improve endothelial function (increase eNOS activity, NO production)
– Reduce blood pressure modestly
– Improve arterial compliance (vessel flexibility)

**Evidence:** Moderate. Consistent evidence for inflammation and oxidative stress reduction. Cardiovascular outcome trials are limited; most evidence is mechanistic and biomarker-based.

**Clinical relevance:** Components of Mediterranean diet (which shows strong cardiovascular benefits). Supplemental evidence is supportive but not as strong as dietary sources.

What This Means Practically: A Comprehensive Cardiovascular Strategy

The Hierarchy of Cardiovascular Risk Reduction (Evidence-Ranked)

1. **Aerobic exercise** (Most powerful): 30-45 min, moderate intensity, 4-5× weekly reduces CVD risk 35-45%
2. **Weight management** (normalization of BMI): Each unit of BMI reduction improves all markers significantly
3. **Smoking cessation** (if applicable): Single largest modifier of CVD risk
4. **Dietary pattern** (Mediterranean or DASH diet): 20-30% CVD risk reduction
5. **Stress management** (chronic stress drives endothelial dysfunction)
6. **Sleep** (adequate sleep 7-9 hours nightly)
7. **Pharmaceutical intervention** (statins, ACE inhibitors, antiplatelet drugs): 25-30% risk reduction
8. **Supplement optimization** (with proven agents): 10-15% additional risk reduction

The hierarchy is clear: lifestyle dwarfs supplements. A man with excellent exercise, diet, sleep, and stress management who takes no supplements has lower risk than a sedentary, poorly-sleeping man taking a cabinet full of supplements.

Practical Supplement Stack for Cardiovascular Health

**Foundation (All Men 40+):**
– **Omega-3**: 2-3g daily (EPA+DHA combined). Reduces triglycerides, CRP, improves endothelial function
– **Magnesium**: 300-400mg daily (to reach adequate intake). Improves blood pressure, endothelial function
– **Vitamin D**: 2000-4000 IU daily (or to reach 30-50 ng/mL serum level). Low D is associated with CVD risk
– **Vitamin B-complex** (including B6, B12, folate): Reduces homocysteine

**Addition (If Specific Risk Factors Present):**
– **Elevated triglycerides (>150 mg/dL):** Add niacin 500-1500mg daily (prescription or high-dose supplements under medical supervision) or additional omega-3
– **Elevated blood pressure:** Add CoQ10 200mg daily, L-citrulline 6-8g daily, beetroot extract (400mg nitrate daily)
– **Elevated LDL or high oxidative stress:** Add lycopene 15-30mg daily, vitamin C 500-1000mg daily, CoQ10 200-300mg daily
– **Elevated CRP or signs of inflammation:** Add curcumin 500-1000mg daily, resveratrol 100-200mg daily, omega-3 (at higher end of range)
– **History of heart failure or reduced cardiac function:** Add taurine 3-6g daily, CoQ10 300-400mg daily
– **Elevated homocysteine:** Ensure adequate B6, B12, folate (often found in B-complex)

**Do NOT Take (Without Medical Guidance):**
– High-dose vitamin E (>400 IU daily): Meta-analyses show increase in hemorrhagic stroke risk
– High-dose calcium supplements (>1200mg daily): May increase arterial calcification; get calcium from food
– Isolated antioxidants (beta-carotene, vitamin A) without dietary support: Can paradoxically increase oxidative stress

The Endothelial Function Angle: Connecting CVD and ED

For men with erectile dysfunction plus cardiovascular risk factors:
– L-citrulline + beetroot extract + omega-3 simultaneously improves endothelial function for both cardiovascular health AND erectile function
– This isn’t coincidental; it’s targeting the shared endothelial dysfunction mechanism
– If ED improves on this regimen, it signals endothelial healing — a positive prognostic sign

Limitations and Nuance

Individual Risk Factor Clustering

Cardiovascular risk is not additive; it’s multiplicative. A man with elevated blood pressure + elevated CRP + elevated triglycerides + poor HDL has risk that’s higher than the sum of individual factors. Conversely, optimization across multiple markers produces disproportionate risk reduction.

Statin Interactions

Men on statins have special considerations:
– Statins deplete CoQ10; supplementation (100-300mg daily) is indicated
– Statins reduce triglycerides effectively; omega-3 provides synergistic benefit
– Some statins increase muscle pain; CoQ10 + adequate vitamin D may reduce this

The CAC Paradox

Men with high CAC scores (advanced atherosclerosis) need pharmaceutical intervention in addition to lifestyle and supplements. Supplements alone cannot reverse advanced calcified plaque. However, supplements can slow progression and reduce acute event risk.

Age and Treatment Targets

Cardiovascular risk reduction strategy depends on age and baseline risk:
– Men under 40 with no risk factors: Lifestyle optimization is the priority; supplements are optional
– Men 40-60 with intermediate risk: Aggressive lifestyle optimization + targeted supplements based on biomarkers
– Men 60+ or with established disease: Pharmaceutical + supplement optimization + close medical monitoring

Key Takeaway: Endothelial Health Is the Foundation; Multiple Markers Must Be Addressed

Cardiovascular disease is a multi-factor disease requiring multi-factor intervention. Single-supplement strategies rarely work because they target only one mechanism.

**The evidence-based approach:**
1. **Establish lifestyle foundation:** Exercise, weight management, Mediterranean/DASH diet, sleep, stress management
2. **Test cardiovascular biomarkers:** Lipid panel, CRP, homocysteine, blood pressure, FMD if available, consider CAC score
3. **Identify individual weak points:** Does this man have elevated triglycerides? Low HDL? High inflammation? High homocysteine?
4. **Supplement strategically:** Address individual weak points with evidence-based agents (omega-3 for triglycerides, magnesium for blood pressure, B-complex for homocysteine, etc.)
5. **Monitor and adjust:** Retest biomarkers in 8-12 weeks; adjust protocol based on response

ED in young men is a cardiovascular warning sign, not just a sexual health issue. Improving endothelial function simultaneously improves both. Comprehensive endothelial support (L-citrulline, nitrates, omega-3, antioxidants) is one of the highest-ROI interventions for men concerned about cardiovascular health.

The promise of supplements is modest but real: 10-15% additional risk reduction beyond excellent lifestyle. That compounds to meaningful protection over decades.

This article summarizes current evidence as of July 2026. Cardiovascular science evolves continuously. Individual cardiovascular risk is complex and multifactorial; this article provides educational context, not personalized medical advice. Men with established cardiovascular disease, family history of early heart attack/stroke, or multiple risk factors should work with a cardiologist to determine appropriate pharmaceutical and supplement strategies. This article is not a substitute for professional cardiovascular risk assessment.